Your browser doesn't support javascript.
loading
Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway.
Li, Ling-Li; Wei, Li; Zhang, Ning; Wei, Wen-Ying; Hu, Can; Deng, Wei; Tang, Qi-Zhu.
Afiliação
  • Li LL; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Wei L; Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, China.
  • Zhang N; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Wei WY; Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, China.
  • Hu C; Department of Pediatrics, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Deng W; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Tang QZ; Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, China.
Biomed Res Int ; 2020: 8593617, 2020.
Article em En | MEDLINE | ID: mdl-32596387
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Doxorrubicina / PTEN Fosfo-Hidrolase / Cardiotoxicidade / Simendana Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Doxorrubicina / PTEN Fosfo-Hidrolase / Cardiotoxicidade / Simendana Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article